Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells-Reference-Cited by-同舟云学术

Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells

Published:2016-04-25 Issue:9 Volume:5 Page:e1175794
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Wiedemann Gabriela Maria,Knott Max Martin Ludwig,Vetter Viola Katharina,Rapp Moritz,Haubner Sascha,Fesseler Julia,Kühnemuth Benjamin,Layritz Patrick,Thaler Raffael,Kruger Stephan,Ormanns Steffen,Mayr Doris,Endres Stefan,Anz David

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1175794

Reference51 articles.

1. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

2. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

3. Inhibition by IL-12 and IFN-α of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells

4. Human Macrophage–derived Chemokine (MDC), a Novel Chemoattractant for Monocytes, Monocyte-derived Dendritic Cells, and Natural Killer Cells

5. Activated Murine B Lymphocytes and Dendritic Cells Produce a Novel CC Chemokine which Acts Selectively on Activated T Cells

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL22 as an independent prognostic factor in endometrial cancer patients;Translational Oncology;2024-12

2. Signaling molecules in the microenvironment of hepatocellular carcinoma;Functional & Integrative Genomics;2024-08-29

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. Association of immune deficiency with prognosis and corticosteroid treatment benefits among patients with acute respiratory distress syndrome;Journal of Thoracic Disease;2024-07

5. Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets;International Journal of Molecular Sciences;2024-06-13